Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,151 | 1,126 | 1,559 | 2,543 | 3,958 |
| TOTAL | $5,297 | $1,253 | $1,671 | $2,727 | $4,072 |
| Non-Current Assets | |||||
| PPE Net | 6,656 | 6,788 | 6,834 | 6,983 | 7,172 |
| Intangibles | 313 | 315 | 317 | 319 | 321 |
| Other Non-Current Assets | 2 | 2 | 3 | 3 | 6 |
| TOTAL | $6,971 | $7,105 | $7,153 | $7,305 | $7,499 |
| Total Assets | $12,268 | $8,357 | $8,824 | $10,032 | $11,571 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,148 | 1,156 | 1,281 | 1,166 | 1,119 |
| Accrued Expenses | 48 | 26 | 26 | 33 | 65 |
| TOTAL | $1,196 | $1,182 | $1,307 | $1,199 | $1,184 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,196 | $1,182 | $1,307 | $1,199 | $1,184 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,595 | 17,997 | 17,431 | 16,072 | 15,641 |
| Retained earnings | -152,848 | -150,627 | -148,842 | -146,746 | -144,529 |
| TOTAL | $11,072 | $7,175 | $7,518 | $8,833 | $10,387 |
| Total Liabilities And Equity | $12,268 | $8,357 | $8,824 | $10,032 | $11,571 |